《Eur Urol Focus》：尿液肿瘤DNA液体活检有望革新膀胱癌管理模式

关键词

膀胱癌 / 尿液肿瘤DNA / 液体活检 / 早期诊断 / 微小残留病灶 / 复发监测

参考文献

[1] LEE J， CHEN F， LOPEZ-BELTRAN A， et al. Urinary tumor DNA-based liquid biopsy in bladder cancer management: a systematic review[J]. Eur Urol Focus， 2025， 11（6）: 978-990.

[2] DUDLEY JC， SCHROERS-MARTIN J， LAZZARESCHI DV， et al. Detection and surveillance of bladder cancer using urine tumor DNA[J]. Cancer Discov， 2019， 9（4）: 500-509.

[3] STRANDGAARD T， LINDSKROG SV， NORDENTOFT I， et al. Elevated T-cell exhaustion and urinary tumor DNA levels are associated with bacillus calmette-guérin failure in patients with non-muscle-invasive bladder cancer[J]. Eur Urol， 2022， 82（6）: 646-656.

[4] RAC G， PATEL HD， JAMES C， et al. Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy[J]. Mol Oncol， 2024， 18（2）: 291-304.

[5] ZHANG R， ZANG J， JIN D， et al. Urinary tumor DNA MRD Analysis to Identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer[J]. Clin Cancer Res， 2023， 29（20）: 4040-4046.

[6] CHAUHAN PS， CHEN K， BABBRA RK， et al. Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: a cohort study[J]. PLoS Med， 2021， 18（8）: e1003732.